Oracle (NYSE:ORCL) Shares Down 5.1% – Should You Sell?

Oracle Corporation (NYSE:ORCL – Get Free Report) shares dropped 5.1% during trading on Monday. The company traded as low as $118.25 and last traded at $118.9370. 19,985,820 shares were traded during mid-day trading, a decline of 35% from the average daily volume of 30,590,713 shares. The stock had previously closed at $125.35.

Recent Oracle Headlines

Here are a few of the latest headlines about ORCL:

  • Positive Sentiment: Shore Medical Center and Shore Physicians Group selected Oracle Health’s AI-powered electronic health record system, expanding Oracle’s healthcare business and extending an existing customer relationship. Article
  • Neutral Sentiment: A report on the e-clinical-trial market forecasts substantial industry growth, with Oracle named among companies in the sector. The article describes a potential market opportunity but does not quantify Oracle-specific gains. Article
  • Negative Sentiment: Oracle ETFs recorded about $747.8 million in net selling on Nov. 12, adding to evidence of investor caution. Article

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on the stock. Yorkville Ives started coverage on shares of Oracle in a research note on Wednesday, October 7th. They issued an “in-line” rating and a $155.00 price objective for the company. DZ Bank reaffirmed a “buy” rating on shares of Oracle in a report on Thursday, September 17th. BMO Capital Markets cut their price target on Oracle from $220.00 to $195.00 and set an “outperform” rating for the company in a research note on Friday, September 11th. The Goldman Sachs Group cut Oracle from a “neutral” rating to a “sell” rating in a report on Monday, November 2nd. Finally, CLSA began coverage on Oracle in a research report on Monday, July 20th. They issued a “hold” rating and a $145.00 price objective on the stock. One equities research analyst has rated the stock with a Strong Buy rating, thirty-seven have issued a Buy rating, five have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $249.27.

Get Our Latest Research Report on Oracle

Oracle Stock Performance

The company has a quick ratio of 1.17, a current ratio of 1.17 and a debt-to-equity ratio of 1.89. The firm has a 50 day moving average of $136.65 and a 200-day moving average of $154.07. The company has a market cap of $359.63 billion, a P/E ratio of 18.64, a PEG ratio of 0.88 and a beta of 1.79.

Oracle (NYSE:ORCL – Get Free Report) last issued its quarterly earnings data on Thursday, September 10th. The enterprise software provider reported $1.92 earnings per share for the quarter, beating analysts’ consensus estimates of $1.74 by $0.18. Oracle had a return on equity of 48.85% and a net margin of 26.36%. The company had revenue of $19.34 billion for the quarter, compared to the consensus estimate of $19.13 billion. During the same quarter last year, the company earned $1.47 earnings per share. The firm’s revenue for the quarter was up 29.6% compared to the same quarter last year. Oracle has set its Q2 2027 guidance at 1.850-1.930 EPS and its FY 2027 guidance at 8.100-8.100 EPS. As a group, sell-side analysts anticipate that Oracle Corporation will post 6.71 EPS for the current fiscal year.

Oracle Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, October 23rd. Investors of record on Friday, October 9th were issued a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 1.7%. The ex-dividend date was Friday, October 9th. Oracle’s dividend payout ratio is 31.35%.

Insider Activity at Oracle

In other news, Director Stephen H. Rusckowski purchased 25,000 shares of the stock in a transaction that occurred on Tuesday, September 29th. The shares were purchased at an average cost of $139.35 per share, with a total value of $3,483,750.00. Following the completion of the acquisition, the director owned 25,390 shares of the company’s stock, valued at approximately $3,538,096.50. This represents a 6,410.26% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Maria Smith sold 2,631 shares of the firm’s stock in a transaction that occurred on Tuesday, September 22nd. The shares were sold at an average price of $151.70, for a total value of $399,122.70. Following the completion of the sale, the executive vice president directly owned 64,357 shares in the company, valued at approximately $9,762,956.90. The trade was a 3.93% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 36,075 shares of company stock worth $5,342,123 over the last three months. Company insiders own 38.40% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the company. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in shares of Oracle by 0.8% during the 2nd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 14,680,278 shares of the enterprise software provider’s stock worth $2,151,395,000 after purchasing an additional 123,294 shares during the last quarter. Fisher Asset Management LLC grew its stake in shares of Oracle by 3.1% in the third quarter. Fisher Asset Management LLC now owns 13,670,982 shares of the enterprise software provider’s stock worth $1,877,026,000 after acquiring an additional 409,531 shares in the last quarter. Bank of New York Mellon Corp acquired a new position in Oracle during the 2nd quarter worth $1,911,930,000. First Eagle Investment Management LLC increased its stake in shares of Oracle by 17.8% during the third quarter. First Eagle Investment Management LLC now owns 10,029,416 shares of the enterprise software provider’s stock worth $1,377,039,000 after buying an additional 1,512,538 shares during the period. Finally, Amundi raised its holdings in shares of Oracle by 1.5% in the 2nd quarter. Amundi now owns 9,878,184 shares of the enterprise software provider’s stock valued at $1,447,648,000 after purchasing an additional 144,087 shares in the last quarter. 42.44% of the stock is owned by institutional investors and hedge funds.

About Oracle

(Get Free Report)

Oracle Corporation is a technology company that develops and provides database software, cloud services, and enterprise applications. Its products help organizations manage data, run business operations, and build and deploy applications. Oracle’s offerings include Oracle Database, Oracle Cloud Infrastructure, and cloud-based applications for functions such as finance, human resources, supply chain management, and customer experience. The company also provides software support, consulting, and related services.

Read More

Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.